Home / D360 and Design Hub Partnership

D360 and Design Hub Integration

Connecting data analysis with compound design to close the DMTA loop and accelerate drug discovery

Better together: close the informatics gap between data analysis-compound design-synthesis with D360-Design Hub integration

The integration of D360 and Design Hub transforms drug discovery by optimizing the Design-Make-Test-Analyze (DMTA) cycle. This integration eliminates manual inefficiencies, allowing researchers to focus on scientific innovation. By uniting data access, analysis, and compound design workflows, D360 and Design Hub empower discovery research teams to make faster, informed decisions and seamlessly track research progress.

Improve the efficiency of the drug discovery process with D360 and Design Hub

The integration of D360 and Chemaxon Design Hub allows scientists to apply design criteria found from data analysis to scientific hypothesis and candidate compounds in Design Hub. The ability to readily turn knowledge into action completes the digitization of the DMTA cycle and allows capture and management of knowledge that is otherwise lost in PowerPoint slides.

Digitalizes the Design-Make-Test-Analyze cycle.

Enables seamless data query, visualization, and compound design.

Tracks and prioritizes candidate compounds through synthesis and testing phases.

How research teams benefit

Integrated compound design and tracking

Chemaxon’s Design Hub connects scientific hypotheses with candidate compound selection and computational capabilities. Researchers can then seamlessly track their designs through synthesis and testing.

Accelerated decision-making

By integrating D360 and Design Hub, researchers can eliminate manual inefficiencies, reduce errors, and accelerate the drug discovery process.

Related products

Enhance drug discovery workflows with D360™, the premier informatics platform for managing and analyzing complex data.

Integrated platform for smaller pharmaceutical teams to seamlessly access, integrate, and analyze data

A complete cheminformatics workbench for molecule design, property calculation, search, data management, and more.

Simcyp PBPK provides physiologically based pharmacokinetic modeling to predict drug behavior in diverse populations.

A validated, web-based application to provide advanced viewing, data summarization, and visualization capabilities for study non-clinical data produced in SEND format.

Why Certara

Certara delivers cutting-edge solutions that empower researchers to accelerate drug discovery and improve decision-making.

Early drug discovery is a core area of expertise at Certara, supported by a team of highly experienced and renowned experts in the field.
Certara’s drug discovery software solutions are widely recognized and accepted by industry leaders.

"D360 is saving us hundreds of hours annually on data analysis. That is an important contribution to our research. The Certara team is tenacious and resourceful. They always find a solution. That’s what has made our relationship so successful.”

Dr. Keith Hornberger
Director of Chemistry, Arvinas

Related resources

View all

1 / 2

On-Demand Webinar

Closing the Loop: How to Improve the Management of Your Design-Make-Test-Analyze Cycle

Scientists in drug discovery often spend excessive time managing research data instead of concentrating on identifying the most promising compounds for new drugs. The right technology streamlines the drug discovery...

Watch now

2 / 2

Fact Sheet

Accelerate your drug discovery research with D360 and Design Hub

Schedule a demo

Discover how D360 and Chemaxon Design Hub integration can transform your drug discovery workflows.

Streamline the Design-Make-Test-Analyze cycle.

Eliminate manual inefficiencies and reduce errors.

Accelerate decision-making with integrated data access and analysis.